MARTINGALE ASSET MANAGEMENT L P
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 936944
BOSTON, MA
Position in VRTX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$21,224,776
+$1,242,111 QoQ
Shares Held
42,729
-4.5% QoQ
Ownership
0.017%
of shares outstanding
% of Portfolio
0.51%
of 13F equity value
Holder Rank
#252
of 1,735 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 74%
Shared 0%
None 26%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MARTINGALE ASSET MANAGEMENT L P holds $144,833,314 across 62 Biotechnology names. VRTX ranks #1 (14.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
42,729 | $21,224,776 | |
| 2 | INCY |
Incyte Corp
|
168,818 | $19,137,208 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
59,492 | $14,335,787 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
18,953 | $11,817,953 | |
| 5 | LGND |
Ligand Pharmaceuticals Inc
|
17,562 | $5,551,172 | |
| 6 | ACAD |
Acadia Pharmaceuticals Inc
|
167,893 | $4,247,692 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
13,634 | $4,104,243 | |
| 8 | INVA |
Innoviva, Inc.
|
165,115 | $3,749,761 |
All Filings in VRTX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $21,224,776 | 42,729 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $19,982,665 | 44,750 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $19,594,672 | 43,221 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $14,303,476 | 36,522 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $18,378,746 | 41,282 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $20,288,262 | 41,847 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $20,621,058 | 51,207 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $24,801,320 | 53,327 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $29,375,619 | 62,672 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $29,255,683 | 69,988 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $31,107,553 | 76,452 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $28,270,218 | 81,297 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $28,818,261 | 81,891 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $26,428,701 | 83,882 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $24,022,164 | 83,185 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $24,795,626 | 85,638 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $18,612,793 | 66,052 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $13,752,075 | 52,696 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $2,419,772 | 11,019 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $967,171 | 5,332 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $17,268,802 | 85,646 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $22,591,385 | 105,130 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $15,982,492 | 67,625 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $34,853,129 | 128,080 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $24,946,047 | 85,929 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $3,490,726 | 14,670 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||